Similar articles

• Preceding transfusions and marrow graft rejection in dogs and man.

  Weiden PL, Storb R, Thomas ED, Graham TC, Lerner KG, Buckner CD, Fefer A, Neiman PE, Clift RA. Weiden PL, et al. Transplant Proc. 1976 Dec;8(4):551-4. Transplant Proc. 1976. PMID: 793113 Review. No abstract available.
• Treatment of bone marrow aplasia by mismatched bone marrow transplantation after conditioning with antilymphocyte globulin--long-term results.

  Mathé G, Schwarzenberg L. Mathé G, et al. Transplant Proc. 1976 Dec;8(4):595-602. Transplant Proc. 1976. PMID: 136773
• Rationale for the use of ALG as sole immunosuppressant in allogeneic bone marrow transplantation for aplastic anemia.

  Speck B, Buckner CD, Cornu P, Jeannet B. Speck B, et al. Transplant Proc. 1976 Dec;8(4):617-22. Transplant Proc. 1976. PMID: 11593 Review. No abstract available.
• Recurrence of aplastic anemia following cyclophosphamide and syngeneic bone marrow transplantation: evidence for two mechanisms of graft failure.

  Appelbaum FR, Cheever MA, Fefer A, Storb R, Thomas ED. Appelbaum FR, et al. Blood. 1985 Mar;65(3):553-6. Blood. 1985. PMID: 3882169
• Bone marrow transplantation in 65 patients with severe aplastic anemia.

  Gluckman E, Devergie A, Gerotta I, Hors J, Sasportes M, Boiron M, Bernard J. Gluckman E, et al. Bull Cancer. 1981;68(1):74-7. Bull Cancer. 1981. PMID: 7013871